Recent ZURA News
- Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024 • Business Wire • 06/14/2024 10:00:00 AM
- Zura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and Immunology • Business Wire • 06/06/2024 10:00:00 AM
- Zura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024 • Business Wire • 06/03/2024 10:00:00 AM
- Zura Bio Announces Participation in June Investor Conferences • Business Wire • 05/29/2024 10:00:00 AM
- Zura Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights • Business Wire • 05/09/2024 10:00:00 AM
- Zura Bio Announces Oversubscribed $112.5 Million Private Placement • Business Wire • 04/18/2024 01:22:00 PM
- Zura Bio Announces Robert Lisicki as CEO and Director • Business Wire • 04/08/2024 10:00:00 AM
- Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer • Business Wire • 03/28/2024 10:00:00 AM
- Zura Bio Announces Participation at March Conferences • Business Wire • 03/04/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:30:45 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:02:53 PM
- Zura Bio Announces Participation at February Investor Conferences • Business Wire • 02/02/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:32:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:30:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 04:27:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:25:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 11:03:32 AM
- Zura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMO • Business Wire • 01/08/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 11:04:01 AM
- Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit • Business Wire • 01/03/2024 11:00:00 AM
- Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok • Business Wire • 12/04/2023 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/17/2023 10:53:10 PM
- Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors • Business Wire • 11/14/2023 11:00:00 AM
- Zura Bio Reports Third Quarter 2023 Financial Results and Recent Business Highlights • Business Wire • 11/13/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 08:30:24 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM